Key Insights Significantly high institutional ownership implies GSK's stock price is sensitive to their trading ...

Read More »

Down 15% and with a P/E below 9! Is the GSK share price still in deep value territory?

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...

Read More »

FTSE 100 Live: Index slips from record; House prices hit record; L&G surges

The FTSE 100 headed lower as trading got underway on Friday, in line with a drop for heavyweights AstraZeneca PLC (LON: AZN) and GSK PLC. London’s blue-chip index slipped 18 points to 8,708 initially, ...

Read More »

London midday: Stocks slightly higher; GSK jumps on guidance upgrade

London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war, with GSK surging after it lifted its long-term sales guidance and ...

Read More »

GSK Raises 2031 Sales Forecast to £40B Amid Strong Specialty Medicine Growth

GSK (LON:GSK) has raised its long-term revenue outlook, now expecting sales to exceed 40 billion by 2031, up from 38 billion. The revision reflects confidence in its expanding specialty medicines ...

Read More »